Valuation Outlook Therapeutics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 00:00:00 31/07/2026 +04			5-day change	1st Jan Change
1.040 ^USD	+4.00%		-21.21%	-34.18%

07-25	Outlook Therapeutics Gains Following FDA Approval of Macular-Degeneration Drug -- Update	DJ
07-24	Outlook Therapeutics Announces LYTENAVA FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet Amd	CI

Data adjusted to current consolidation scope

Fiscal Period: September	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	380.5	275.9	57.51	126.3	47.08	194.5	-	-
Change	-	-27.49%	-79.15%	119.63%	-62.73%	313.04%	-	-
Enterprise Value (EV)	380.5	275.9	57.51	126.3	47.08	194.5	194.5	194.5
Change	-	-27.49%	-79.15%	119.63%	-62.73%	313.04%	0%	0%
P/E	-6.2x	-3.94x	-0.92x	-1.32x	-0.59x	-2.19x	-5.38x	11.6x
PBR	71.9x	29.6x	-	-	-	-	-	-
PEG	-	0.3x	0x	0.1x	0x	0x	0.1x	-0x
Capitalization / Revenue	-	-	-	-	33.3x	47.2x	3.35x	2.65x
EV / Revenue	-	-	-	-	0x	47.2x	3.35x	2.65x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-4.19x	-7.64x	9.71x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-7	-6.2	-4.8	-4.06	-1.79	-0.475	-0.1933	0.09
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	-	-	1.413	4.122	58	73.31
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-51.73	-63.07	-53.13	-71.7	-67.06	-46.4	-25.46	20.03
Net income ¹	-53.16	-66.05	-58.98	-75.37	-62.42	-47.92	-32.34	20.8
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	43.400	24.400	4.420	5.340	1.060	1.040	1.040	1.040
Nbr of stocks (in thousands)	8,767	11,307	13,012	23,656	44,420	186,997	-	-
Announcement Date	22/12/21	29/12/22	22/12/23	27/12/24	19/12/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
OUTLOOK THERAPEUTICS, INC.	-2.11x	-	-	-	187M
LONZA GROUP AG	33.57x	6.03x	17.92x	0.96%	48.95B
IQVIA HOLDINGS INC.	32.11x	3.13x	13.52x	-.--%	40.75B
REVOLUTION MEDICINES, INC.	-22.58x	337.47x	-20.61x	-.--%	38.46B
BEONE MEDICINES AG	48.6x	4.95x	32.02x	-.--%	36.38B
CELLTRION, INC.	27.45x	7.94x	19.96x	0.42%	28.45B
MEDPACE HOLDINGS, INC.	33.26x	5.44x	24.73x	-.--%	16.33B
ICON PUBLIC LIMITED COMPANY	25.19x	1.99x	12.05x	-.--%	13.65B
EUROFINS SCIENTIFIC SE	22.83x	2x	8.66x	1.16%	13.56B
Average	22.04x	46.12x	13.53x	0.32%	26.3B
Weighted average by Cap.	24.62x	58.99x	12.91x	0.32%